82 results on '"Montaner J."'
Search Results
2. High prevalence of willingness to use direct‐acting antiviral‐based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs
3. The effect of engagement in an HIV/AIDS integrated health programme on plasma HIV‐1 RNA suppression among HIV‐positive people who use illicit drugs: a marginal structural modelling analysis
4. Assessment of enlarged perivascular spaces and their relation to target organ damage and mild cognitive impairment in patients with hypertension
5. Non-HIV-related health care utilization, demographic, clinical and laboratory factors associated with time to initial retention in HIV care among HIV-positive individuals linked to HIV care
6. Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies
7. Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability
8. Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada
9. Proteolytic activity of circulating microparticles from ischemic stroke patients revealed by single particle laser scanning confocal microscopy: OR314
10. Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada
11. Modelling clinical progression and health care utilization of HIV-positive patients in British Columbia prior to death
12. How to unfasten the Spanish Stroke Belt? Andalusia chooses research
13. A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy
14. P218tPA in combination with MMP-10 a new effective strategy for thrombolysis in ischemic stroke with neuroprotective effect
15. Genetic aspects of inflammatory response mediated by IL-6 following spontaneous intracerebral hemorrhage (SICH): a case control study: EP1128
16. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy*
17. Rates of new infections in British Columbia continue to decline at a faster rate than in other Canadian regions
18. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage
19. Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings
20. Decreased Levels of Angiogenic Growth Factors in Intracranial Atherosclerotic Disease despite Severity-Related Increase in Endothelial Progenitor Cell Counts
21. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality
22. Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users
23. Matrix Metalloproteinases in Human Spontaneous Intracerebral Hemorrhage: An Update
24. Brain Natriuretic Peptide Is Associated with Worsening and Mortality in Acute Stroke Patients but Adds No Prognostic Value to Clinical Predictors of Outcome
25. Treatment limitations imposed by antiretroviral drug resistance mutations: implication for choices of first line regimens in resource-limited settings
26. Relationship of Chronic Hepatitis C Infection to Rates of AIDS-Defining Illnesses in a Canadian Cohort of HIV Seropositive Individuals Receiving Highly Active Antiretroviral Therapy
27. The gender gap in stroke: a meta-analysis
28. No evidence of APP point mutation and locus duplication in individuals with cerebral amyloid angiopathy
29. A panel of biomarkers including caspase-3 and d-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department
30. Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort
31. O2-S5.03 Sex, drugs and structural interventions: unstable housing associated with increased HIV risk behaviour in a cohort of people on treatment in British Columbia, Canada
32. Leukoaraiosis is associated with genes regulating blood-brain barrier homeostasis in ischaemic stroke patients
33. GASOMETRIC ANALYSIS OF BLOOD SAMPLES DIRECTLY OBTAINED BEYOND ARTERIAL MCA OCCLUSION DURING ENDOVASCULAR PROCEDURES PREDICTS RESPONSE TO REVASCULARIZATION: 16
34. The I/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals
35. Improving stroke thrombolysis (tPA) safety through the use of plasma biomarkers: O15A-2
36. Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme
37. Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users
38. WHAT CAN WE LEARN FROM OTHER DISEASES: HIV/AIDS
39. Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers
40. Mortality is influenced by locality in a major HIV/AIDS epidemic
41. Condom use among injection drug users accessing a supervised injecting facility
42. Health care services utilization stratified by virological and immunological markers of HIV: evidence from a universal health care setting
43. Public injecting among a cohort of injecting drug users in Vancouver, Canada
44. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users
45. MMP-9-RELATED MECHANISMS OF T-PA-INDUCED HEMORRHAGIC TRANSFORMATION: A GENOMIC, PROTEOMIC AND HISTOLOGICAL ANALYSIS IN HUMAN STROKE: 2
46. PAI-1 4G5G POLYMORPHISM IS ASSOCIATED WITH BRAIN VESSEL REOCCLUSION RATES AFTER FIBRINOLYTIC THERAPY AMONG ISCHEMIC STROKE PATIENTS: 4
47. TNK INDUCES FASTER MCA RECANALIZATION AND BETTER SHORT-TERM OUTCOME THAN NATIVE TPA. THE TNK-TPA REPERFUSION STROKE STUDY: 9
48. ASSOCIATION BETWEEN GENETIC VARIANTS IN THE LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) AND ANGIOTENSIN-CONVERTING ENZYME (ACE) GENES AND CEREBRAL AMYLOID ANGIOPATHY: 3
49. TIMING OF MICROBUBBLE-ENHANCED SONOTHROMBOLYSIS STRONGLY PREDICTS INTRACRANIAL HEMORRHAGE IN ACUTE ISCHEMIC STROKE: 5
50. Timing of Microbubble-Enhanced Sonothrombolysis Strongly Predicts Intracranial Hemorrhage in Acute Ischemic Stroke: 03
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.